Malignant Mesothelioma - Can we Improve Quality of Life

NACompletedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

April 3, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

April 10, 2017

Conditions
Mesothelioma, Malignant
Interventions
OTHER

Regular Early Specialist Symptom Control Treatment (RESSCT)

"Participants will be seen within three weeks of randomisation by the Specialist Palliative Care Team (SPCT), (regardless of, and in addition to, all other treatments being offered). The initial meeting will be an approximately 1 hour consultation with a member of the Specialist Palliative Care team. This may be either a Consultant or Specialist Palliative Care Clinical Nurse Specialist (SPCCNS).~Patients will then continue to be seen regularly on at least a 4 weekly basis (regardless of other treatments, interventions and symptoms) by a member of the SPCT, with consultations lasting approximately 30 minutes. These monthly reviews will continue until end of trial (EOT) or patient death."

Trial Locations (19)

WA 6009

Sir Charles Gairdner Hospital, Nedlands

DL3 6HX

County Durham and Darlington NHS Foundation Trust, County Durham

SS16 5NL

Basildon and Thurrock University Hospitals NHS Foundation Trust - Basildon Hospital, Basildon

CM1 7ET

Mid Essex Hospital Services NHS Trust - Broomfield Hospital, Chelmsford

RG24 9NA

Hampshire Hospitals NHS Foundation Trust, Basingstoke

PO6 3LY

Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Portsmouth

SO16 6YD

University Hospital Southampton NHS Foundation Trust, Southampton

NR4 7UY

Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich

NG17 4JL

Sherwood Forest Hospitals NHS Foundation Trust, Nottingham

NG3 6AA

Nottinghamshire Healthcare NHS Foundation Trust, Nottingham

TA1 5DA

Taunton and Somerset NHS Foundation Trust - Musgrove Park Hospital, Taunton

IP4 5PD

Ipswich Hospital NHS Trust, Ipswich

NE29 8NH

Northumbria Healthcare NHS Foundation Trust, North Shields

SN3 6BB

Great Western Hospital NHS Foundation Trust, Swindon

BS10 5NB

North Bristol NHS Trust - Southmead Hospital, Bristol

M23 9LT

University Hospital of South Manchester NHS Trust, Manchester

M8 5RB

Pennine Acute Hospitals NHS Trust, Manchester

NE34 OPL

South Tyneside NHS Foundation Trust, South Shields

WV10 0QP

The Royal Wolverhampton NHS Trust, Wolverhampton

All Listed Sponsors
collaborator

British Lung Foundation

OTHER

collaborator

University of Oxford

OTHER

lead

Portsmouth Hospitals NHS Trust

OTHER_GOV

NCT03068117 - Malignant Mesothelioma - Can we Improve Quality of Life | Biotech Hunter | Biotech Hunter